MENU
United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.38B
P/E Ratio
15.88
Total Cash
2.97B
Projected Growth
1.41
Total Debt
500M
Revenue
2.62B
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash/Share
66.79
Total Debt/Equity
21.97
Revenue/Share
53.19 USD as % of share price
Fundamentals
UTHR
Capitalization
15.4B
P/E Ratio
15.88
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash
2.97B
Total Cash/Share
66.79
Total Debt
500M
Total Debt/Equity
21.97
Projected Growth (PEG Ratio)
1.41
Revenue/Share (as % of the share price)
53.19%
Revenue
2.62B
ROE
N/A
Book Value
5.7B
P/B Ratio
2.70
Cash Flow
N/A
Earnings
23.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
700K
Current Ratio
4.35
Current Revenue Per Employee
612071.94
Dividends Per Share - Security
N/A
EBITDA
1.52B
Float
N/A
Float - Current
N/A
Gross Income Margin
89.12
Revenue To Assets
15.96
Shares Held By Institutions
37.1B
Shares Outstanding - Current
44.5M
Total Liabilities
1.03B
Total Volume MTD
N/A
Value
-1
Gain YTD
59.280
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com